Answer
Besremi (ropeginterferon alfa-2b) has a minor influence on driving and using machines; patients experiencing dizziness, somnolence or hallucinations during treatment should avoid these activities.
Sources for this answer
- Besremi 250 micrograms/0.5 mL solution for injection in pre-filled penAOP Orphan Ltd · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 10Document updated
Sources checked